Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

22 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,118,138 shares of 87,441,936 outstanding shares and own 24.15% of the company stock.
Largest 10 shareholders include FMR LLC (12,000,000 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,296,107 shares), Redmile Group, LLC (2,500,000 shares), Velan Capital Investment Management LP (600,000 shares), Parian Global Management LP (466,676 shares), VANGUARD GROUP INC (442,344 shares), Hongkou Capital LP (400,000 shares), Saba Capital Management, L.P. (400,000 shares), Alpine Global Management, LLC (384,988 shares), and CVI Holdings, LLC (200,000 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.